Investigative site

Paris 75015

1 studies enrolling now · 4 studies all time

What they study most

Alport Syndrome, CLE, Cutaneous Lupus Erythematosus (CLE), Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, Pancreatic Cancer, SLE, SLE (Systemic Lupus), Systemic Lupus Erythematosus

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Recruiting now
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria — Completed